Search Results
May 26, 2026, 13:28 ET Data analysis by ECRI on patient falls reveals common risk factors
alarms or checklists; it requires understanding how care is actually delivered and experienced in real clinical environments," said Polly Tremoulet, PhD, Director of Human Factors Engineering at ECRI. "When we apply human factors-based systems thinking after a fall or near-miss, we seek to understand
More news about: ECRI
May 26, 2026, 11:53 ET OneR and OneOncology Partner Practice Investigators to Present 23 Abstracts at ASCO 2026
the deep commitment of OneR investigators to bringing the latest research to clinical trials to patients in their communities," said Ian Flinn, MD, PhD, Chief Scientific Officer at OneOncology. "As innovation accelerates, OneOncology partner practices continue to deliver high-quality patient care,
More news about: OneOncology, LLC.
May 26, 2026, 09:41 ET Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science
to Insilico's mission since its inception. The company's journey gained industry notice in 2015 at the NVIDIA GTC conference, where Alex Zhavoronkov, PhD, founder and CEO of Insilico, challenged the tech world with a provocative question:
More news about: Insilico Medicine
May 26, 2026, 09:33 ET Lupus Research Alliance and Genentech Fund Researchers Translating CAR T Success into Durable Lupus Treatments
questions."Moving from early breakthrough clinical trials to effective therapies requires a strong scientific foundation," said Teodora Staeva, PhD, Chief Scientific Officer of the Lupus Research Alliance. "By supporting these studies with our long-standing partner Genentech, we are deepening our
More news about: Lupus Research Alliance
May 26, 2026, 09:32 ET New Parkinson's Foundation PD Trial Navigator Program Identifies 2,000+ Potential Participants for NEULARK Clinical Trial
participants with groundbreaking clinical trials," said Executive Vice President and Chief Scientific Officer of the Parkinson's Foundation, James Beck, PhD. "The initial success with genetically identifying individuals for the NEULARK trial is encouraging, as the combined power of the PD GENEration database
More news about: Parkinson's Foundation
May 26, 2026, 09:03 ET American Specialty Health Expands Network Capabilities by Including Home-Based and Mobile PT/OT Services
(APTA)."Physical and occupational therapy is most effective when it reflects how people actually move and function in their daily lives," said Jaynie Bjornaraa, PhD, MPH, PT, who is the senior vice president of clinical quality evaluation and digital self-care solutions at ASH. "This model aligns closely with the
More news about: American Specialty Health Incorporated
May 26, 2026, 09:00 ET Adam & Eve Explores the Solo Satisfaction Index
females) said masturbation resulted in less intense orgasm than with a partner."May is International Masturbation Month," says Dr. Jenni Skyler, PhD, LMFT, C-PST, and Adam & Eve's resident sex therapist, "so it's the perfect time to talk about the rarely discussed act of self-love. It's important
More news about: adameve.com
May 26, 2026, 09:00 ET Adela Highlights Progress on Multi-Cancer Early Detection Study at the 2026 ASCO Annual Meeting
richest cancer signals in the blood, particularly for detecting early-stage disease and identifying cancer signal of origin," said Daniel De Carvalho, PhD, Co-Founder and Chief Scientific Officer at Adela. "Adela's genome-wide methylome enrichment platform is designed to capture that signal while preserving
More news about: Adela
May 26, 2026, 08:57 ET Crew Scaler Releases Landmark Agentic AI Security Study for Multi-Agent Systems
Nguyen is CEO of Crew Scaler and a Senior AI and security expert in the U.S. government. Moses Ndebugre is a Senior Researcher at Crew Scaler and a PhD candidate in Electrical and Computer Engineering at NC A&T. Dheeraj Arremsetty is an AI Technical Solution Architect at IBM and an Advisory Board
More news about: Crew Scaler
May 26, 2026, 08:32 ET ABILITY Neurotech Receives IMDD Approval to Start Clinical Trial for Chronic Implantation of Brain-Computer Interface in ALS Patients
use."Receiving approval for our first chronic implantation study is a defining moment for both ABILITY and for the broader BCI field," said Rotem Kopel, PhD, CEO of ABILITY Neurotech. "The industry has long focused on proving neural interfaces can work in controlled environments. This study moves the field
More news about: ABILITY Neurotech
May 26, 2026, 08:32 ET CancerCare® and Pioneer Institute Release Study on the Financial Outcomes and Community Benefit in the 340B Program: Comparing 340B and Non-340B Hospitals
patients."A program which once worked well, 340B is now problematic for some hospitals in its size, function, and outcomes," said William Smith, PhD, Senior Fellow, Pioneer Institute. "The deep discounts once given to and used by 340B hospitals in economically disadvantaged neighborhoods to help underserved
More news about: CancerCare
May 26, 2026, 08:30 ET Avoid Post-FACS Sorting Delays: Choosing the Best Single B Cell Workflow for Antibody Discovery, Upcoming Webinar Hosted by Xtalks
Register for this webinar to learn how to choose the right post-FACS single B cell workflow for Antibody Discovery.Join Alain Agnememel, PhD, Principal Scientist, Antibody Discovery,
More news about: Xtalks
May 26, 2026, 08:30 ET Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing
Matthew Oberley, MD, PhD, SVP, Chief Clinical Officer and Pathologist-in-Chief at Caris Life Sciences. "Erika's case illustrates what an AI-augmented, physician-in-the-loop approach
More news about: Caris Life Sciences
May 26, 2026, 08:05 ET Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference
participants will include Helen Sabzevari, PhD, President and CEO, and Phil Tennant, Chief Commercial Officer.The Goldman Sachs 47th Annual Global Healthcare Conference will be held from June 8 to 10, 2026, in Miami Beach, Florida. Helen Sabzevari, PhD, President and CEO, Precigen, will participate
More news about: Precigen, Inc.
May 26, 2026, 08:05 ET New Creative Nonfiction Biography Tells the Story of Willi Graf, the White Rose Resister Whose Christian Faith Led Him to Defy Hitler
Barnes & NobleAbout the authorDr. Deborah Lee Prescott earned a BA, MA and PhD in literature, with her doctoral research focused on Holocaust survivors' autobiographies. She has traveled extensively throughout Germany and Poland,
More news about: WestBow Press
May 26, 2026, 08:00 ET 28bio Launches CNS-3D Alzheimer's Model to Predict Therapeutic Efficacy
progression."Disease-modifying therapies require models that capture how Alzheimer's pathology develops and disrupts human brain function over time," said Christopher Butt, PhD, Vice President of Technology at 28bio. "With the CNS-3D Induced Alzheimer's Model, researchers can generate human-relevant insights into disease biology
More news about: 28bio
May 26, 2026, 08:00 ET GHGSat Appoints Jean-Marc Nasr as Independent Chair of the Board
and CEO of Spot Image, commercialising the SPOT satellite constellation's imagery on global markets. He holds an Engineering Degree from SUPELEC and a PhD in Physics from Paris University, and has been recognised as Chevalier de la Légion d'honneur and Chevalier de l'Ordre national du Mérite. This
More news about: GHGSAT INC
May 26, 2026, 07:30 ET Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
outbreak of Bundibugyo virus, an Orthoebolavirus, will require new vaccine formulation efforts. Soligenix, in collaboration with Axel Lehrer, PhD, Professor at the Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaiʻi at
More news about: SOLIGENIX, INC.
May 26, 2026, 07:30 ET Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
and related post-acute infection syndromes often face lengthy diagnostic journeys and limited objective testing options," said Dr. Sean Knight, MD, PhD, Principal Investigator at the Lydia Becker Institute of Immunology and Inflammation, University of Manchester, and Consultant Respiratory Physician
More news about: Virax BioLabs Group Limited
May 26, 2026, 03:49 ET Global Times: Chinese, Bangladeshi, Pakistani researchers gather in Shanghai to breed better fish and closer ties
productive, taller and bigger," she told the Global Times by a pond of the base.Arif is drawn to the mysteries of heredity. Now pursuing her PhD in aquaculture at SHOU and mainly working on epigenetics, Arif traces her scientific interest back to her earlier years, when she spent hours gazing
More news about: Global Times
May 26, 2026, 03:00 ET MatOrtho、ReCerf® 5A* ODEP格付けを発表
www.recerf.com をご覧ください。MatOrthoについてMatOrthoは、股関節表面置換術と人工膝関節置換術を専門とする英国の整形外科機器メーカーです。メディアお問い合わせ先：Michael Watson PhD MCIMマーケティング＆プロダクト・マネジメント担当責任者MatOrtho電話番号：01372 224200Eメール：[email protected] ウェブサイト
More news about: MatOrtho
May 26, 2026, 03:00 ET MatOrtho announces ReCerf® 5A* ODEP rating
UK-based orthopaedic device company specialising in hip resurfacing and knee replacement technologies.Media contact:Michael Watson PhD MCIMHead of Marketing & Product ManagementMatOrthoTel: 01372 224200Email:
More news about: MatOrtho
May 26, 2026, 03:00 ET MatOrtho announces ReCerf® 5A* ODEP rating
UK-based orthopaedic device company specialising in hip resurfacing and knee replacement technologies.Media contact:Michael Watson PhD MCIMHead of Marketing & Product ManagementMatOrthoTel: 01372 224200Email:
More news about: MatOrtho
May 26, 2026, 03:00 ET MatOrtho kündigt ReCerf® 5A* ODEP-Bewertung an
Geräte, das sich auf Technologien für das Hüft-Resurfacing und den Knieersatz spezialisiert hat.Medienkontakt:Michael Watson PhD MCIMLeiter der Abteilung Marketing & ProduktmanagementMatOrthoTel: 01372 224200E-Mail:
More news about: MatOrtho
May 26, 2026, 03:00 ET MatOrtho anuncia la calificación 5A* para ReCerf®de ODEP
de dispositivos ortopédicos especializada en tecnologías de reemplazo de cadera y rodilla.Contacto para medios: Michael Watson PhD MCIMResponsable de Marketing y Gestión de Producto MatOrthoTel: 01372 224200Email:
More news about: MatOrtho